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ABSTRACT
Objective: The purpose of this investigation was to determine the effect of chitosan on osteoclast cells by observing cell viability, bone resorption, 
and radical oxygen species (ROS) production.
Methods: Osteoclast cells were obtained from the primary culture of bone marrow mouse. The osteoclast cells were identified by tartrate-resistant 
acid phosphatase (TRAP) marker both on the cells and the culture medium. The osteoclast cell viability was observed with (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium assay and Bradford assay for total protein medium culture, while ROS production was measured 
with malondialdehyde (MDA) assay. Slices of cow cortical bone were used as a substrate for osteoclastic resorption and concentrated hydrochloric 
acid were used to activate resorption and pit formation by any osteoclasts.
Results: Osteoclast cells were identified by TRAP marker and chitosan treated group cells showed lower optical density value compared to control 
(p<0.05) on TRAP assay medium culture. Cell viability indicated lower on chitosan group than control (p<0.05). There was a qualitative difference of 
the pits formed on the bone surface between the control and the chitosan group. There was a significant difference in MDA (mmol/ml) between the 
control and the chitosan group with (p<0.05).
Conclusion: Based on this research, we conclude that chitosan inhibits the viability of osteoclast cells, decreases ROS production and bone resorption.
Keywords: Chitosan, Osteoclast proliferation, Radical oxygen species, Bone resorption.
INTRODUCTION
Chitosan is a biodegradable and non-toxic chitin derivative with a low 
molecular weight of 34.8 kDa and a high molecular weight of 800-
1500 kDa. Its chemical structure is similar to hyaluronate [1-3]. This 
biomaterial can take various forms and has various functions. It is 
available in a variety of useful forms as gel, membrane, fiber, beads, 
powder, flakes and solution. Previous research has reported that chitosan 
is capable of increasing hemostasis, decreasing fibroplasia, facilitating 
osteogenesis and increasing tissue regeneration [3-7]. In the field of 
dentistry, Xu et al. reported the usage of chitosan as barrier membrane 
material in periodontal regeneration [8]. Chitosan gel alone or its 
combination with demineralize bone matrix membrane is promising 
for periodontal regeneration [9]. Arnaud et al. reported chitosan effect 
on dentinal enamel demineralization: An in vitro evaluation [10]. A 
self-setting composite consisting of chitosan/tricalcium phosphate 
microparticles showed a high degree of cytocompatibility and seemed 
to be a “user-friendly” material for oral surgeons [11].
The healing process of bone fractures or bone defects is a complex 
process. The healing requires integration and coordination among 
specific cells. There are three specific cells, i.e. osteoblast, osteocyte and 
osteoclast, which have a function in the formation and remodeling of 
bones. The effect of chitosan on osteoblast cells has been extensively 
reported. Chitosan can induce the osteoblast differentiation and bone 
formation (in vitro) [1,3,12-14]. However, the effect of chitosan on 
osteoclast cells has not been much documented. Osteoclast is a giant 
bone cell with multiple nuclei that plays a role in bone resorption and 
bone remodeling. Like macrophage cells, osteoclast can produce radical 
oxygen that can cause damage to the surrounding tissues.
In vitro research, osteoclast can be obtained from the culture of the 
bone marrow of test animals [15,16]. The aim of this investigation 
was to determine the effect of chitosan, an Indonesian material with 
special specifications produced by Indonesia National Nuclear Energy 
Agency (BATAN). Therefore, this study was to evaluate the interaction 
of chitosan with cells participating in tissue engineering, especially 
osteoclast. The osteoclast cells were observed by studying their cell 
viability, bone resorption, and radical oxygen species (ROS) production. 
For this research, osteoclast is obtained from the culture of the bone 
marrow of mice, which has already been extensively used in research 
on the formation of osteoclast cells with multiple nuclei from its 
progenitors.
METHODS
This was an in vitro study using osteoclast cell culture. The osteoclast 
cells were identified by osteoclast tartrate-resistant acid phosphatase 
(TRAP) marker (Primary Cell Co. Ltd., Sapporo, Japan) both on the cells 
and the culture medium. Then the osteoclast cell viability was observed 
with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay (Invitrogen, Washington) and Bradford assay (Thermo 
Scientific, Rockford, USA) for total protein medium culture, while ROS 
production was measured with malondialdehyde (MDA) assay (Sigma). 
Concentrated hydrochloric acid (HCl 37%) 82 µl/100 ml was added 
to the last medium change of the osteoclast cell culture to activate the 
osteoclast cells [16].
Cell culture
Osteoclast cells were obtained from the primary culture of the bone 
marrow of a 2-9 weeks old mouse. Long bones were dissected from 
one or two mice killed by general anesthetic solution. The bones were 
cut across the epiphyses, and the marrow was flushed out with PBS 
using a 25-gauge needle (Terumo Corporation, Japan). The resulting 
suspension was centrifuged (Sorvall Legant RT Kendro, Germany) 
at 2000 g, 20 minutes and resuspended in culture medium. This cell 
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suspension was cultured at 4 × 105 in a 24 well plate. Cell cultures were 
performed using Dulbecco modified eagles medium (Invitrogen) with 
10% fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin 
and amphotericin B (Biowest, South America) supplemented with 
10 nM 1α,25(0H)2D3 (A.G Scientific, Inc. San Diego) as control in a 
condition of 37°C and 5% CO2 for a duration of 6-8 days, according 
to the method described by  (1994) and Timothy (2003) [13,14]. The 
culture medium was changed every day while adding 1α,25(OH)2D3. 
The osteoclast cells resulting from the culture were identified by 
osteoclast TRAP markers (Primary Cell Co. Ltd., Sapporo, Japan) 
both on the osteoclast cells and the culture medium, following the 
manufacturer’s instruction.
Chitosan
For this research, we used chitosan produced by BATAN Indonesia, 
and the specifications were acetic acid soluble, molecular weight 
34.8 kDa sterilized by 25 kGy of gamma irradiation and the degree of 
deacetylation was 72-82%. Chitosan 0.2% percent in 0.2% acetic acid 
was added to the treatment group by placing the chitosan on the basis 
of the culture dish or on top of the bone slices of the treatment group 
before cells were seeded in the culture dish, whereas no chitosan was 
administered to the control group.
MTT assay
Osteoclasts on 24 well tissue culture plates were divided into two 
groups; control and treatment groups. The osteoclast cells proliferation 
was observed with MTT assay, following the manufacturer’s instruction 
(Invitrogen, Washington). Briefly, 75 µl of the 5 mg/ml MTT solution 
was added per well (24 well plates) and incubated for additional 3 hrs. 
750 µl acidified isopropanol was added per well and was shaken on a 
shaker at room temperature for 1 hr. The optical density (OD) of each 
sample was measured at 490 nm.
Bradford assay
Total protein in medium culture was observed with Bradford assay. 
To make a standard curve protein, we used 512 µg/ml, 256 µg/ml, 
128 µg/ml, 64 µg/ml bovine serum albumin (BSA) (Albumin Standard 
Thermo Scientific, Rockford, USA). Then, 160 µl of culture medium 
or BSA was transferred to a 96 well plate, added with 40 µl Bradford 
reagent (Thermo Scientific, Rockford, USA), and was incubated at room 
temperature for 5 minutes. The total protein of the culture medium 
was measured with a microplate reader (Biorad, Benchmark) at 
655 nm [17].
MDA assay
ROS production was measured with MDA assay. The MDA used was from 
Aldrich SIGMA. Briefly, 2 ml sample cell or standard MDA was added 
with 1 ml trichloroacetic acid 20% and 2 ml thiobarbituric acid 0.67%, 
and then heated in a boiling water bath for 10 minutes. Absorbance was 
read at 530 nm [18].
Measurement of bone resorption
Slices of cow cortical bone were used as a substrate for osteoclast 
resorption. Bone slices (1 cm diameter and 1 mm thick) were cut 
from a cleaned adult cow femur using a water-cooled diamond saw 
(Struers Accutom-2 and Struers LaboPol-21). The slices were washed 
extensively in distilled water and further sterilized by ultraviolet light 
radiation before use. The bone slices were placed at the bottom of a 24 
well plate. The cells were allowed to settle onto the bone slices. The 
culture medium was replaced every 2-3 days; the final replacement was 
with medium acidified by the addition of 82 µl/100 ml concentrated 
hydrochloric acid (37%) to activate resorption and pit formation by 
any osteoclasts formed, according to the method described by Arnett 
et al. [16]. Bone resorption was observed and the pits formed on the 
bone slices were observed. Bone resorption pits were qualitatively 
observed by phase contrast Microscope Olympus Tokyo, ×20 and 
Olympus F.8 Camedia C 4040 Z00m Digital Camera. Bone resorption 
was indicated as score 1-3: Pit bone resorption (1), lacuna bone 
resorption (2), and diffuse bone resorption (3).
Statistical analysis
The differences between treatment, and control using MTT, Bradford 
assays, MDA assay and TRAP marker identification on culture medium 
were tested using t-test, with p<0.05.
Ethical approval
All experiments using mouse were approved by the Faculty of Dentistry 
University of Indonesia Experimental Ethic Committee.
RESULTS
Identification of osteoclast using cells and culture medium
Osteoclast cells were identified by TRAP, both on control and chitosan 
treatment groups. Fig. 1 shows phase contrast photomicrographs of 
5 days osteoclasts culture, identified by TRAP, showed (Fig. 1a) control 
and (Fig. 1b) osteoclasts culture treated with chitosan. Both control 
and treatment groups showed positive TRAP staining, with higher cell 
quantity and stronger intensity in the control group. Fig. 2 shows OD 
value of TRAP assay from osteoclasts culture medium in the control 
was 0.67 ± 0.07 and chitosan treated group was 0.59 ± 0.08. T-test 
independent analysis showed that there was a significant difference 
between the control group and chitosan-treated group (p<0.05).
Cell viability
Based t-test statistical analysis, there was a significant difference of 
mean OD in MTT assay between control group 1.51 ± 0.17 and chitosan 
treated group 0.88 ± 0.18 (p<0.05) (Fig. 3). Based on t-test statistical 
analysis, there was a significant difference of mean total protein in 
culture medium (Bradford assay) between control group 2237.62 ± 
439.92 µg/ml, chitosan treated group 1963.67 ± 331.71 µg/ml (p<0.05).
Fig. 2: Optical density value of tartrate-resistant acid phosphatase 
assay from osteoclasts culture medium in the control and 
chitosan treated group (error bars show standard errors) n=3
Fig. 1: Phase contrast photomicrographs of 5 days osteoclasts 
culture, identified by tartrate-resistant acid phosphatase, showed 
(a) control and (b) osteoclasts culture treated with chitosan, (×200)
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Bone resorption
Bone resorption pits were qualitatively observed by giving a microscopic 
score (mean score from five fields per sample). Fig. 4 showed the 
resorption on the bone slice. The Arnett et al. method was used for the 
observation of bone resorption. A phase contrast photomicrograph 
demonstrated pits on the surface of bone slices. Fig. 4a and b shows 
that osteoclasts were activated by HCl addition in the culture medium 
on the last medium change. From the observation, score from 1 to 3 was 
determined. Score 3 was determined on the pits of control group (A), 
and score 1 and 2 on the pit of chitosan treated group (B).
ROS product
An MDA assay was done to evaluate ROS product. This osteoclast 
product was measured by a spectrophotometer on λl 530 nm. MDA 
assay result in the control group was 0.83 ± 0.21 mmol/ml and 
chitosan treated group was 0.51 ± 0.06 mmol/ml. The independent 
t-test analysis showed that there was a significant difference between 
the control group and chitosan treated group (p<0.05) as depicted 
on Fig. 5.
DISCUSSION
Chitosan is a biomaterial derived from chitin with a molecular weight 
of 800-1500 kDa and a chemical structure similar to hyaluronate. For 
this research we used chitosan (produced by BATAN, Indonesia) with 
special specification i.e. a molecular weight of 34.8 kDa. Previous 
study reported the potential stimulating ability of chitosan (BATAN) 
in dental pulp stromal/stem cells proliferation and early osteogenic 
differentiation comparable with that of dexamethasone, but no 
significant stimulation on mineral deposition [3]. The role of chitosan in 
bone regeneration and remodeling, and the healing process has already 
been reported, both with animals and humans [2,3,9,19-21]. Bone is a 
dynamic tissue that always renews and can remodel itself. The effect 
of chitosan on osteoblast cells has been extensively reported, but the 
healing process of fractured or defect bones are a complex process. 
The healing requires integration and coordination between specific 
cells. One of them is osteoclast, which in principle, plays a role in bone 
resorption and remodeling. Through this research, we showed that 
chitosan could influence osteoclast cells. Osteoclast cells were obtained 
through the culture of bone marrow of mouse for duration of 5-8 days 
by  using a modified culture method previously used by Arnett et al. 
[16] and Soekanto et al. (1998) [15]. In order to change pre-osteoclast 
into immature osteoclast and subsequently into mature osteoclast that 
plays a function in bone resorption, a receptor activator of nuclear factor 
kB ligand, which is produced by osteoblast cells, is needed [15,16].
In our preliminary study for the osteoclast cell culture, two types of 
controls were used, namely 1α,25(OH)2D3 only (first control) and 
1α,25(OH)2D3 with a culture medium of osteoblast (second control). 
This was done because in a number of previous researches, various 
growth factors were used. The effect of chitosan on osteoclast cell 
proliferation was tested with MTT assay. The results of preliminary 
study showed that there was no signification difference in the OD value 
of MTT assay between first control and second control (unpublished). 
This means that an increase in the growth factor does not increase 
osteoclast proliferation. Therefore, during the following tests, we only 
used one growth factor, 1α, 25(OH)2D3.
In order to identify osteoclast cells that were formed in mouse bone 
marrow culture for a duration of 5-8 days, we used TRAP kit as 
osteoclast cell marker. TRAP is widely used as a marker of osteoclast 
in bone. Protein is released by osteoclast during bone resorption 
and therefore, TRAP can also be used as bone resorption marker in 
culture media [22,23]. Osteoclasts are bone cells that originate from 
hematopoietic stem cells that are able to resorb bone by secreting acid 
and proteinase [24]. The results of this research showed that TRAP 
positive cells, were present in the control and treatment group with a 
different intensity, as seen in Fig. 1. Moreover, Fig. 1a and b shows the 
osteoclast cell culture with the addition of HCl at the change of the last 
medium (low pH). In the low pH condition, TRAP positive cells in the 
control group had clear color intensity and changed to their size, while 
in the treatment group the color intensity was unclear. From this result, 
it is assumed that chitosan, apart from obstructing osteoclast cell 
viability, also obstructs the change from fused polykaryon (immature 
osteoclast) to mature osteoclast. Both immature osteoclast and 
mature osteoclast express TRAP. The TRAP-secreted into the culture 
medium - was measured on a wavelength of 490 nm. A significant 
difference occurred in TRAP culture medium between control and 
Fig. 3: Optical density value of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide assay, between the control and 
chitosan treated group (error bars show standard errors) n=3
Fig. 5: Value (mmol/ml) of malondialdehyde assay in control group 
and chitosan treated group (error bars show standard errors) n=4
Fig. 4: A phase contrast photomicrograph showed the pit on the 
surface of bone slices. Score 3 was determined in the control 
group (a) and score 1 and 2 in the chitosan treated group (b) (×200)
ba
Asian J Pharm Clin Res, Vol 8, Issue 5, 2015, 282-286
 Suniarti et al. 
285
treatment group (p<0.05), as seen in Fig. 2. This result was support 
by Li et al., low molecular weight chitosan inhibits the formation of 
TRAP positive osteoclast induced by 1α,25(OH)2D3 [25]. Rochet 
et al., reported that chitosan inhibits formation of TRACP positive 
cells. Inhibition of TRACP activity on 2% chitosan in combination with 
calcium phosphate cement did not result from inhibitory effect at 
transcription level, but might result from a inhibition of the enzymatic 
activity of the TRACP [21]. Chitosan influences osteoclast proliferation, 
as shown by the result of MTT assay (Fig. 3). The fact that the OD 
value of the treatment group smaller than that of the control group 
with significant statistical difference (p<0.05) was supported by the 
result of total protein in culture medium. The total protein medium 
of the treatment group was lower than that of the control group. 
This result indicated that protein production by cells in treatment 
groups decreased, perhaps due to inhibited osteoclast proliferation. 
Rochet et al. reported that 2% chitosan in combination with calcium 
phosphate cement does not affect the proliferation and adhesion of 
pre-osteoclast but inhibits the formation of TRACP positive cells and 
prevents the osteoclastic resorption on the composite biomaterial 
compared to calcium phosphate cement alone [21].
Halleen et al., reported that the ROS generating activity of TRACP 
may have important role both in bone resorption and in the immune 
defense system [26-28]. The effect of chitosan on bone resorption has 
been observed in bone slices 1 cm in diameter and 1 mm thick. This 
research showed that chitosan inhibits bone resorption. The difference 
between control and treatment group was observed qualitatively, 
namely by giving a score of 1-3 to the bone resorption picture that 
appeared on the bone slice. This was done because the tools for 
quantitative observation were limited. The patterns and amount of 
pit that was formed on the bone slices differed between control and 
treatment group. The score for the control group was higher (score 3) 
than the score for the treatment group (score 1 and 2) shown in Fig. 5. 
Bone resorption score in this research could be interpreted as bone 
resorption present in bone slices, but this score was not sensitive 
and needs more clarification on the depth and the surface area of 
resorption. These findings are supported by previous research, 
which reported resorption lacunae on 2% chitosan in combination 
with calcium phosphate cement were never detected. Possibly there 
is a negligible inhibiting effect of chitosan on osteoclastogenesis was 
reported by Rochet et al. [21]. In addition, chitosan can obstruct 
the occurrence of bone loss in a mouse model that has received 
ovariectomy [2]. During bone resorption, osteoclast releases various 
components into the resorption environment. The components include 
a number of acids and proteinase. Apart from this, it was reported that 
at the same moment osteoclast produces ROS. It was reported that 
superoxide anion occurred both inside and outside osteoclast in the 
areas of bone resorption. Therefore, it is assumed that ROS plays a role 
in bone resorption [29,30]. For this research, in order to understand 
the effect of chitosan on ROS production of osteoclast cells, we have 
measured MDA, which is a lipid membrane peroxydation product [18]. 
A significant difference in MDA value was obtained between control 
and treatment group, (p<0.05) (Fig. 4). Konga et al. (2009) reported 
that the water-soluble derivatives of chitosan and chitin were potent 
antioxidant and matrix metalloproteinase 2 and 9 in HT 1080 human 
fibrosarcoma [30]. The radical scavenging activities of chitosan depend 
on their degree of deacetylation and concentration. The optimal 
concentration of chitosan was 0.2 mg/ml [29,31].
CONCLUSION
Based on this research we can conclude that chitosan from National 
Nuclear Energy Agency (BATAN, Indonesia) inhibits the viability of 
osteoclast, decreases ROS production and bone resorption.
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